The Health Bureau announced today (Aug. 1) that the Chronic Disease Co-care Pilot Scheme (CDCC Pilot Scheme) has expanded the coverage of its basic-tier drug list from 59 items to 114 items starting from today. The expansion provides participating family doctors with more drug choices to cater for the different clinical prescription needs of participants in the Scheme.
The basic-tier drug list of the CDCC Pilot Scheme covers commonly used drugs for treating chronic diseases (such as anti-hypertensive drugs, lipid-regulating and anti-diabetic drugs) and episodic illnesses. Under government subsidy, participants prescribed with drugs on the list will not be required to pay for such medication.
The government included 55 additional drug items in the basic-tier drug list starting from August 1, covering antidepressants and drugs for the management of chronic hepatitis B, osteoporosis and thyroid disorder. Additionally, more drugs were added to address health problems associated with episodic illnesses, such as drugs for relieving asthma exacerbation, gout, nausea and vertigo. The expanded drug list now covers 114 basic-tier drug items, up from 59 items previously, providing family doctors with greater flexibility to cater for the clinical needs of participants.
The CDCC Pilot Scheme has been well received since its launch, with over 140,000 participants enrolled in the Scheme to date. As of July 23 (provisional figures), about 85,000 participants have completed the screenings, of which around 34,000 (i.e. about 40 per cent) have been diagnosed with prediabetes, DM, HT or hyperlipidaemia and have proceeded to the treatment phase. The Government will continue to promote the CDCC Pilot Scheme to encourage citizens to prevent and manage chronic diseases proactively, thereby enhancing the overall health of the general public.
Related News:
7-Eleven launches 'big discount days': 20% off on purchases over HK$100 for 3 days
Comment